What is it about?
We cover identifying and stratifying risk during routine examination, practical monitoring and screening schedules, tools for the diagnosis of patients with TD, and individualized evidence-based treatment strategies for patients with tardive dyskinesia.
Featured Image
Why is it important?
We owe our patients the aspirational goals of striving for zero prevalence of persistent symptoms of TD and improved functioning and quality of life in anyone treated for psychosis.
Perspectives
Despite significant recent progress reviewed herein, many questions remain for future research including the mechanisms underlying TD, genetic predisposition, phenomenological diversity, whether new cases are reversible, how to implement best practices to prevent and treat TD, and whether the development of novel antipsychotics free of the risk of TD is attainable.
Dr. Stanley N. Caroff
University of Pennsylvania
Read the Original
This page is a summary of: A new era in the diagnosis and treatment of tardive dyskinesia, CNS Spectrums, October 2022, Cambridge University Press,
DOI: 10.1017/s1092852922000992.
You can read the full text:
Contributors
The following have contributed to this page
